GleamWall
中文EN

USAQ QHSLab, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 856984 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.1%
TTM net income YoY213.1%
TTM EPS YoY150.0%
Revenue 3-yr CAGR29.5%
Net income 3-yr CAGR—

Margins

Gross margin68.2%
Operating margin-2.2%
Net margin14.8%
FCF margin—
EBITDA margin0.3%

Returns

ROE97.8%
ROA25.1%
ROIC (approx.)-23.4%
Asset turnover1.70x

Leverage & solvency

Liabilities / assets14.1%
Debt / equity0.00x
Current ratio2.10x
Interest coverage-1.03x

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio38.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$677,172$847,490$728,685$703,810$737,066$605,446$645,419$625,981
Cost of revenue$208,709$257,706$257,882$215,551$243,435$206,431$215,475$213,827
Gross profit$468,463$589,784$470,803$488,259$493,631$399,015$429,944$412,154
R&D expense$115,074$114,621$120,909$115,707$132,769$112,364$124,033$107,530
SG&A expense$244,705$255,416$207,822$120,952$131,415$149,818$155,523$83,400
Operating income-$50,404$45,245-$94,380$35,506$96,251$11,526-$12,039$73,077
Interest expense$2,741$7,215$9,526$42,519$62,840$64,484$67,570$360,744
Pretax income-$53,145$38,030-$103,906$556,573$33,411-$52,958-$79,609—
Net income-$53,145$38,030-$103,906$556,573$33,411-$52,958-$79,609-$287,589
EBITDA-$32,376$63,273-$76,352$53,534$114,279$29,554$24,605$109,721
EPS (basic)0.000.000.00—0.000.00-0.01—
EPS (diluted)0.000.000.00—0.000.00-0.01—
Weighted avg. shares (diluted)15.03M23.08M15.03M—19.33M11.28M11.19M—
Balance sheet
Cash & equivalents$190,464$317,392$362,088$636,157$158,391$168,358$61,065$157,168
Receivables$308,923$342,886$201,202$190,610$210,131$148,191$194,978$196,089
Inventory—$8,814$27,517$35,790$26,619$42,264$29,192$41,779
Current assets$519,108$682,933$619,058$883,009$428,599$385,980$325,814$420,827
Intangibles$1.23M$1.25M$1.27M$1.29M$1.31M$1.32M$1.34M$1.36M
Total assets$1.75M$1.93M$1.89M$2.17M$1.73M$1.71M$1.67M$1.80M
Current liabilities$247,114$375,822$368,005$449,860$2.35M$2.35M$2.26M$2.41M
Long-term debt——$36,877$90,704————
Total debt——$36,877$90,704————
Total liabilities$247,114$375,822$368,005$546,078$2.35M$2.35M$2.26M$2.41M
Shareholders' equity$1.51M$1.56M$1.52M$1.62M-$610,912-$644,323-$591,365-$607,756
Net debt——-$325,211-$545,453————
Shares outstanding15.03M15.03M15.03M15.03M11.28M11.28M11.28M10.81M
Cash flow statement
Operating cash flow-$126,928-$7,819-$200,242$98,033$2,601$127,033-$49,549$55,050
Financing cash flow$0-$36,877-$73,827$379,733-$12,568-$19,740-$46,554$6,173
Depreciation & amortization$18,028$18,028$18,028$18,028$18,028$18,028$36,644$36,644
Stock-based compensation$5,664$0$0$0$0$0$0$1,258

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.